Because of the role of NCOA4 in ferritinophagy and ferroptosis, we evaluate Gpx4 expression in sorted bone marrow erythroblasts, demonstrating no differences between WT, MDS, and DFP-treated MDS mice (Figure 8—figure supplement 2). Here, GPX4 is linked to myelodysplastic syndrome.